Methyl 3-((tert-butoxycarbonyl)amino)thiophene-2-carboxylate, 95.0%, 5g

3-Amino-4-bromo-5-phenyl-1H-pyrazole, 95.0%, 5g

3',5'-dichloro-4-(5,5-dimethyl-1,3-dioxan-2-yl)butyrophenone, 97.0%, 1g

11-DeoXycorticosterone, 250mg

2,2,4,4-Tetramethyloxetan-3-aminehydrochloride, 98%, 250mg

Ethyl 5-Methyl-1-phenyl-1H-1,2,3-triazole-4-carboxylate, 1g

3,4-Dibromofuran, 95.0%, 100mg

4-(4-METHYLPIPERAZIN-1-YLSULFONYL)PHENYLBORONIC ACID PINACOL ESTER, 95.0%, 10g

4-Bromo-D-Phe-OH, 96%, 500g

iScope IS.1153-PLPHi Triocular with Plan phase IOS objectives and Rackless cross table (infinity)

2-(tert-Butoxycarbonyl)-2-azaspiro[3.4]octane-5-carboxylic acid, 98%, 250mg

4,8-Dichloroquinoline>98.0%(GC)5g

tert-Butyl 2-(chloromethyl)-2-(hydroxymethyl)pyrrolidine-1-carboxylate, 97%, 100mg